BLUE SAIL MEDICAL released its performance for the first half of the year, with a net loss attributable to the parent company of 135 million yuan, narrowing by 15.88%
According to the Zhitong Finance APP, BLUE SAIL MEDICAL released its semi-annual report for 2025, showing an operating income of 2.781 billion yuan, a year-on-year decrease of 7.49%. The net loss attributable to shareholders of the listed company was 135 million yuan, a year-on-year narrowing of 15.88%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 210 million yuan, a year-on-year increase of 11.82%. The basic loss per share was 0.13 yuan
According to the Zhitong Finance APP, BLUE SAIL MEDICAL (002382.SZ) released its semi-annual report for 2025, reporting an operating income of 2.781 billion yuan, a year-on-year decrease of 7.49%. The net loss attributable to shareholders of the listed company was 135 million yuan, a year-on-year narrowing of 15.88%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 210 million yuan, a year-on-year increase of 11.82%. The basic loss per share was 0.13 yuan
